These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35092043)

  • 1. Effect of nutrition status and inflammatory stimuli on ghrelin and peptide-YY levels among critically ill children: A prospective and observational study.
    Zaher S; White D; Ridout J; Branco RG; Meyer R; Pathan N
    JPEN J Parenter Enteral Nutr; 2022 Aug; 46(6):1298-1306. PubMed ID: 35092043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is There a Role for Enterohormones in the Gastroparesis of Critically Ill Patients?
    Santacruz CA; Quintairos A; Righy C; Crippa IA; Couto L; Imbault V; Wasineeart M; De Ryckere M; Preiser JC
    Crit Care Med; 2017 Oct; 45(10):1696-1701. PubMed ID: 28737574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations of circulating peptide YY and ghrelin with body weight, rate of weight gain, and time required to achieve the recommended daily intake in preterm infants.
    Chen X; Du X; Zhu J; Xie L; Zhang Y; He Z
    Braz J Med Biol Res; 2012 Jul; 45(7):656-64. PubMed ID: 22527125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children.
    Bizzarri C; Rigamonti AE; Luce A; Cappa M; Cella SG; Berini J; Sartorio A; Müller EE; Salvatoni A
    Eur J Endocrinol; 2010 Mar; 162(3):499-505. PubMed ID: 20019130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macronutrient Regulation of Ghrelin and Peptide YY in Pediatric Obesity and Prader-Willi Syndrome.
    Gumus Balikcioglu P; Balikcioglu M; Muehlbauer MJ; Purnell JQ; Broadhurst D; Freemark M; Haqq AM
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3822-31. PubMed ID: 26259133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide YY (3-36) represents a high percentage of total PYY immunoreactivity in preterm and full-term infants and correlates independently with markers of adiposity and serum ghrelin concentrations.
    Siahanidou T; Mandyla H; Militsi H; Papassotiriou I; Chrousos G
    Pediatr Res; 2007 Aug; 62(2):200-3. PubMed ID: 17597642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in appetite related gut hormones in intensive care unit patients: a pilot cohort study.
    Nematy M; O'Flynn JE; Wandrag L; Brynes AE; Brett SJ; Patterson M; Ghatei MA; Bloom SR; Frost GS
    Crit Care; 2006 Feb; 10(1):R10. PubMed ID: 16420657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating peptide YY concentrations are higher in preterm than full-term infants and correlate negatively with body weight and positively with serum ghrelin concentrations.
    Siahanidou T; Mandyla H; Vounatsou M; Anagnostakis D; Papassotiriou I; Chrousos GP
    Clin Chem; 2005 Nov; 51(11):2131-7. PubMed ID: 16155093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ghrelin PYY 3-36 serum changes in left ventricular hypertrophic, insulin-resistant, hypertensive obese patients.
    Karcz-Socha I; Zwirska-Korczala K; Zembala M; Borgiel-Marek H; Karcz K
    Obes Facts; 2011; 4(5):386-92. PubMed ID: 22166759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut hormone activity of children born to women with and without gestational diabetes.
    Chandler-Laney PC; Bush NC; Rouse DJ; Mancuso MS; Gower BA
    Pediatr Obes; 2014 Feb; 9(1):53-62. PubMed ID: 23364910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feeding the critically ill obese patient: a systematic review protocol.
    Secombe P; Harley S; Chapman M; Aromataris E
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):95-109. PubMed ID: 26571286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal and meal-stimulated ghrelin, PYY, CCK levels and satiety in lean women with polycystic ovary syndrome: effect of low-dose oral contraceptive.
    Arusoglu G; Koksal G; Cinar N; Tapan S; Aksoy DY; Yildiz BO
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4475-82. PubMed ID: 24001751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of postprandial profiles of ghrelin, active GLP-1, and total PYY to meals varying in fat and carbohydrate and their association with hunger and the phases of satiety.
    Gibbons C; Caudwell P; Finlayson G; Webb DL; Hellström PM; Näslund E; Blundell JE
    J Clin Endocrinol Metab; 2013 May; 98(5):E847-55. PubMed ID: 23509106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
    Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of plasma acetylcholine and inflammatory markers in critically ill patients during early enteral nutrition: A prospective observational study.
    Tao G; Min-Hua C; Feng-Chan X; Yan C; Ting S; Wei-Qin L; Wen-Kui Y
    J Crit Care; 2019 Aug; 52():219-226. PubMed ID: 31108325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meal-related changes in ghrelin, peptide YY, and appetite in normal weight and overweight children.
    Lomenick JP; Clasey JL; Anderson JW
    Obesity (Silver Spring); 2008 Mar; 16(3):547-52. PubMed ID: 18239577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide YY directly inhibits ghrelin-activated neurons of the arcuate nucleus and reverses fasting-induced c-Fos expression.
    Riediger T; Bothe C; Becskei C; Lutz TA
    Neuroendocrinology; 2004; 79(6):317-26. PubMed ID: 15256809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome.
    Zwirska-Korczala K; Sodowski K; Konturek SJ; Kuka D; Kukla M; Brzozowski T; Cnota W; Woźniak-Grygiel E; Jaworek J; Bułdak R; Rybus-Kalinowska B; Fryczowski M
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():161-78. PubMed ID: 18812636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated circulating ghrelin, but not peptide YY(3-36) levels, in term neonates with infection.
    Siahanidou T; Margeli A; Tsirogianni C; Hantzi E; Papassotiriou I; Chrousos G
    Clin Chem Lab Med; 2015 Oct; 53(11):1815-24. PubMed ID: 25870965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ghrelin and Peptide YY Change During Puberty: Relationships With Adolescent Growth, Development, and Obesity.
    Cheng HL; Sainsbury A; Garden F; Sritharan M; Paxton K; Luscombe G; Hawke C; Steinbeck K
    J Clin Endocrinol Metab; 2018 Aug; 103(8):2851-2860. PubMed ID: 29860506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.